📰 Thomas Theuringer News
Page 3 - Thomas Theuringer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomas Theuringer. Real-time updates on events, politics, business and more.
June 20, 2023
Venlo, the Netherlands, and San Diego, California, June 20, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) announced today that the U.S. Federal Bureau of Investigation (FBI) has approved
June 20, 2023
NDIS approval provides access to federal government funding for accredited public crime laboratories in the U.S. to implement next-generation sequencing for routine casework // NGS-based ForenSeq... | June 20, 2023
June 16, 2023
Venlo, the Netherlands, June 15, 2023 -- QIAGEN welcomes the publication of a new, systematic review highlighting the unique value of its proprietary tuberculosis testing technology. The study... | June 15, 2023
June 13, 2023
Venlo, the Netherlands, and Redwood City, California, June 13, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced that its variant interpretation and reporting software, QIAGEN
April 24, 2023
Venlo, the Netherlands, April 24, 2023 -- QIAGEN announced today that its QIAstat-Dx syndromic testing solution is expected to be available soon for use in Japan with a SARS-CoV-2 Respiratory... | April 24, 2023
March 13, 2023
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December
March 1, 2023
First partnership in the new QIAseq Platform Partnership to increase compatibility of QIAGEN NGS kits with third-party digital data-sharing and analytics companies Bringing together QIAGEN's
February 15, 2023
Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class CCertification marks milestone in QIAGEN’s transition to full compliance with new EU regulations for IVD performance and safetyQIAGEN will ensure continuous supply of QuantiFERON-TB Gold PlusVENLO, The Netherlands--(...
February 14, 2023
Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class C Certification marks milestone in QIAGEN's transition to full compliance with new EU regulations
February 7, 2023
Q4 2022: Net sales of $498 million (-14% at actual rates, -9% at constant exchange rates, CER); diluted EPS of $0.39 and adjusted diluted EPS of $0.53 Net sales at CER of $531 million